Share

|

|

|

>

  • Showcases
  • >
  • Pooled analysis demonstrates favorable safety profile for risdiplam
Clinician using a tablet device

Pooled analysis demonstrates favorable safety profile for risdiplam

 Maria Mazurkiewicz-Bełdzińska outlines a pooled analysis of data from the FIREFISH, SUNFISH, and JEWELFISH trials, which demonstrates that risdiplam has a favorable benefit–risk profile in patients with spinal muscular atrophy (3:42).

Don’t fall behind!

Get the latest headlines – in your specialties of choice – delivered straight to your inbox.

Showcase

MEET THE SENIOR TEAM

Lucy Piper

medwireNews Bureau Chief

Related Showcases

|